M&A Deal Summary |
|
|---|---|
| Date | 2023-12-20 |
| Target | Vyleesi |
| Sector | Life Science |
| Buyer(s) | Cosette Pharmaceuticals |
| Sellers(s) | Palatin Technologies |
| Deal Type | Divestiture |
| Deal Value | 171M USD |
SEARCH BY
Cosette Pharmaceuticals is a US-based, fully integrated pharmaceutical company with capabilities in product development, manufacturing, and commercial operations. The current products focus on complex dosage forms including topical creams, ointments, oral liquids/solutions, suppositories, and injectables. Cosette Pharmaceuticals is based in Bridgewater, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Divestiture M&A Deals | 2 of 2 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-18 |
Daiichi Sankyo - Eight Branded Products
Tokyo, Japan Daiichi Sankyo - Eight Branded Products' provides sales and distribution rights in United States. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Life Science |
| Employees | 30 |
| Revenue | 4M USD (2024) |
Palatin Technologies discover and develop novel therapeutics for patients living with inflammatory and autoimmune conditions. Palatin Technologies was incorporated in 1986 and is based in Cranbury, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
